PPARD and pulmonary arterial hypertension: PPARβ/δ was activated by prostacyclin [15] suggesting that the beneficial effects of prostacyclin therapy, the current treatment of choice for many patients with severe pulmonary hypertension, could be mediated in part through activation of PPARβ/δ.